• Topics

  • Formats

Like it or not, there is a revolution at hand for medical affairs teams. There will be those who embrace the change and ride the wave to a meaningful, collaborative, cross-functional role in pharma, and those who get left behind in the weeds of 'vanity' metrics and disjointed tactics.

Whether you’re a new or veteran listener to my BioPharma Revolution podcast then you know we’re traveling in the fast lane with the pirates over here. So buckle up because this episode is a treasure chest full of medical affairs plunder.

Our guest is Carlos Eid, Cardiovascular Executive Medical Director at Novartis and a self-confessed pirate of pharma. I saw him speak at a conference and knew right away that I had to have him on the show… and I’m so happy he accepted.

You are attempting to log out of MyMA

Do you really want to log out?